HCAT Q1 2026 Earnings Earnings Beat Sentiment but Stock Slips APRE Q1 2026 Earnings Narrower Loss Beats Estimates Stock Rises 215 Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues BEBE Q3 2016 Earnings EPS Plunges 194 Below Estimates as Operating Losses Deepen UHT Q1 2026 Earnings Solid EPS Performance Amidst Modest Stock Gain Black Diamond Therapeutics BDTX Q1 2026 Earnings EPS Beat Fails to Lift Stock as Pipeline Uncertainty Lingers